Search

Your search keyword '"Cook, Jackie"' showing total 900 results

Search Constraints

Start Over You searched for: Author "Cook, Jackie" Remove constraint Author: "Cook, Jackie"
900 results on '"Cook, Jackie"'

Search Results

101. Technical Workflow Development for Integrating Drone Surveys and Entomological Sampling to Characterise Aquatic Larval Habitats of Anopheles funestus in Agricultural Landscapes in Côte d’Ivoire

103. Web of Dreams.

104. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer

105. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

106. Pre-intervention characteristics of the mosquito species in Benin in preparation for a randomized controlled trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors

107. Additional file 1 of Assessing the efficacy of two dual-active ingredients long-lasting insecticidal nets for the control of malaria transmitted by pyrethroid-resistant vectors in Benin: study protocol for a three-arm, single-blinded, parallel, cluster-randomized controlled trial

110. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008

111. No evidence that GATA3 rs570613 SNP modifies breast cancer risk

112. A founder UMODvariant is a common cause of hereditary nephropathy in the British population

113. UK recommendations for SDHAgermline genetic testing and surveillance in clinical practice

114. Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa

115. Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial

116. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

117. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

118. Additional file 8 of Exploring the link between MORF4L1 and risk of breast cancer

119. Additional file 7 of Exploring the link between MORF4L1 and risk of breast cancer

120. Additional file 16 of Exploring the link between MORF4L1 and risk of breast cancer

121. Additional file 5 of Exploring the link between MORF4L1 and risk of breast cancer

122. Additional file 9 of Exploring the link between MORF4L1 and risk of breast cancer

123. Additional file of Exploring the link between MORF4L1 and risk of breast cancer

124. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

125. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

126. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (vol 22, 8, 2020)

127. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

128. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study:a double-blind, randomised, placebo-controlled trial

129. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk:an international prospective cohort of BRCA1 and BRCA2 mutation carriers

130. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

131. Interim Results from the IMPACT Study:Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

132. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

137. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

138. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma

141. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis

142. Gene–gene interactions in breast cancer susceptibility

144. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

146. Prostate Cancer Risk by BRCA2 Genomic Regions

147. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

148. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

149. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

150. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

Catalog

Books, media, physical & digital resources